3D bioprinter Koligo Therapeutics to list on ASX
18 March, 2019Koligo Therapeutics, a regenerative medicine and 3D bioprinting company, will list on the Australian Securities Exchange at the end of March via an initial public offering.
New drug developed to treat heart attack damage
15 March, 2019UK researchers are working to develop drugs that could be given in the first few hours following a heart attack to minimise heart muscle death caused by the stress signals.
Fungus-based peptide found to kill TB bacteria
11 March, 2019Researchers have discovered a potential new pharmaceutical candidate for tuberculosis, finding that the antimicrobial peptide NZX rapidly and effectively kills TB bacteria.
Horse sperm can now be stored unfrozen for longer
08 March, 2019Scientists have developed a nutrient-rich liquid that enables collected horse semen to live for two weeks outside the body without the need to be frozen.
Positive trial results for peanut allergy therapy
01 March, 2019Trial data showed that Melbourne biotech company Aravax's therapy has a highly favourable safety profile, even in patients with severe peanut allergies.
Antivirals cut liver cancer risk in Hep C patients
28 February, 2019Direct-acting antivirals have been found to be associated with a reduced risk of liver cancer and death in people with chronic hepatitis C.
RecA protein and DNA-damage response
07 February, 2019Researchers have used molecular 'Velcro' to understand how an important protein, RecA, goes about repairing damaged DNA in bacteria.
Statin therapy found safe and effective in over 75s
06 February, 2019Statin therapy is safe and effective in older people over 75 years and reduces major vascular events such as heart attacks and strokes, according to new research.
Standard antibiotics courses may be too long
01 February, 2019Australian researchers are claiming that shorter courses of antibiotics are nearly always as effective as longer ones for many common infections.
Virus engineered to target and kill cancer cells
30 January, 2019Scientists have engineered a virus that selectively targets and kills cancer cells, with a stronger anticancer effect than another engineered virus currently used in clinical practice.
Cartherics and ToolGen sign a deal on CAR-T therapy
24 January, 2019Australia's Cartherics and Seoul-based ToolGen have teamed up to bring innovative immunotherapies for cancer a step closer to reality.
Solving the genetics puzzle
07 January, 2019 by Mansi GandhiGrowing up in Germany, Melanie Bahlo used to record which birds came and visited her bird feeder in the depths of winter. She was around eight years old at the time and loved discovering new things.
Cannabis-based drug relieves symptoms of motor neuron disease
18 December, 2018Chemical compounds derived from the cannabis sativa plant, used as an add-on treatment, may help ease symptoms of spasticity in people with motor neuron disease.
Brain-stimulation implant could treat epilepsy patients
04 December, 2018A tiny device that electrically stimulates the brain could one day be used to treat conditions such as epilepsy and Parkinson's disease — without open-brain surgery.
Roadmap released for regenerative medicine sector
28 November, 2018MTPConnect's report 'Regenerative Medicine: Opportunities for Australia' provides a roadmap for elevating the sector so it can successfully compete at a global level.
